Clinically, specific subtypes of breast cancer are defined by their histopathological appearance and expression of hormone receptors and growth factors [namely, the estrogen receptor (ER), the progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2; also known as ERBB2]. This evidence concerns the gene ERBB2 and breast carcinoma.